News

Dotmatics becomes member of Alliance which seeks to define the future of Life Sciences R&D information management.

Gedeon Richeter will provide USD $5-million convertible loan to Evestra.

A chemical in garlic kills bacteria that cause deadly infections in people with cystic fibrosis, University of Edinburgh research shows.

The Royal Academy of Engineering’s Enterprise Hub has identified seven of the most promising inventors based in UK universities and is supporting them to turn their research into spin-out companies.

Project focused on potential small molecule or antibody targets in pathways important in the development or progression of respiratory disease.

The science of synesthesia; fear generalization & PTSD; emotion recognition treatment in autism, and more.

Transplanted human stem cells treated with drug boost myelin synthesis and improve auditory function in a preclinical study Damage to myelin, the fatty insulator that enables communication between nerve cells, characterizes multiple sclerosis (MS) and other devastating neurological diseases.

Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer’s disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.

Getting rejected hurts depressed people for longer, study finds – due to the lack of a natural pain and stress-reducing chemical Rejected by a person you like? Just “shake it off” and move on, as music star Taylor Swift sings.

Immune Signatures in Blood Point to Distinct Disease Stages, Open Door to Better Diagnosis and Treatment Researchers at the Center for Infection and Immunity at Columbia University's Mailman School of Public Health identified distinct immune changes in patients diagnosed with chronic fatigue syndrome, known medically as myalgic encephalomyelitis (ME/CFS) or systemic exertion intolerance disease.